vidarabine phosphate has been researched along with Peripheral Nerve Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lok, AS; Thomas, HC; Wilson, LA | 1 |
| Bruguera, M; Kanterewicz, E; Lamarca, J; Rodés, J; Viola, C | 1 |
1 trial(s) available for vidarabine phosphate and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Neurotoxicity associated with adenine arabinoside monophosphate in the treatment of chronic hepatitis B virus infection.
Topics: Adolescent; Adult; Arabinonucleotides; Chronic Disease; Female; Hepatitis B; Humans; Male; Middle Aged; Muscular Diseases; Nervous System Diseases; Pain; Peripheral Nervous System Diseases; Prospective Studies; Risk; Vidarabine Phosphate | 1984 |
1 other study(ies) available for vidarabine phosphate and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Toxic neuropathy after adenine arabinoside treatment in chronic HBsAg-positive liver disease.
Topics: Arabinonucleotides; Chronic Disease; Female; Hepatitis B Surface Antigens; Humans; Liver Cirrhosis; Middle Aged; Paresthesia; Peripheral Nervous System Diseases; Vidarabine Phosphate | 1990 |